These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [A new pyrazol derivative in the treatment of certain rheumatic diseases; clinical trials]. SCHIAVETTI A; SCHIAVETTI L Minerva Med; 1958 Dec; 49(103):4865-9. PubMed ID: 13622412 [No Abstract] [Full Text] [Related]
26. [Effect of immunoglobulin on the microbial flora of the tonsils in patients with rheumatism]. Ermalinskiĭ AF; Tkachenko LA; Savin VR; Shul'ga VV; Gubar' EA Vrach Delo; 1988 Nov; (11):53-5. PubMed ID: 3266390 [No Abstract] [Full Text] [Related]
27. [Butazolidine, an antirheumatic agent]. LOVGREN O Sven Lakartidn; 1957 Mar; 54(13):959-63. PubMed ID: 13433538 [No Abstract] [Full Text] [Related]
28. [Adrenocortical function, antistreptolysin titer and blood sedimentation in rheumatic patients under therapy with pyrazole derivatives]. KUHNE P; SCHATTMANN K; SENFT G; UNVERRICHT W Z Rheumaforsch; 1956 Aug; 15(7-8):197-208. PubMed ID: 13393258 [No Abstract] [Full Text] [Related]
29. [Phenylbutazone in rheumatism]. SPINDLER S Dia Med; 1954 Nov; 26(79):2357-9. PubMed ID: 13220428 [No Abstract] [Full Text] [Related]
30. [Hydroxy-phenylbutazone in the treatment of chronic inflammatory rheumatisms]. Fernández del Vallado P; Gijón Baños J; Gálvez Failde JM; Beltrán Gutiérrez J Rev Clin Esp; 1967 Apr; 105(1):46-51. PubMed ID: 5303402 [No Abstract] [Full Text] [Related]
31. [Clinical trial of the association of phenylbutazone and paracetamol in extra-articular rheumatism]. Gamarski J Hospital (Rio J); 1966 Sep; 70(3):675-8. PubMed ID: 5300275 [No Abstract] [Full Text] [Related]
32. [Clinical experiences with a new pyrazole combination]. PENDENZA G Minerva Med; 1958 Mar; 49(24):1114-8. PubMed ID: 13552217 [No Abstract] [Full Text] [Related]
33. The treatment of chronic rheumatism with butazolidin. KELLY M Med J Aust; 1953 May; 1(20):690-4. PubMed ID: 13062907 [No Abstract] [Full Text] [Related]
34. [Therapeutic results of butazolidin in chronic rheumatism]. GOLZ G Medizinische; 1954 Oct; 44():1480-2. PubMed ID: 13223292 [No Abstract] [Full Text] [Related]
35. [Research on the therapeutic activity and tolerance of a new antirheumatic drug (1,4-diphenyl-3, 5-pyrazolidinedione aminophenazone)]. CAGIANELLI MA; PANESI M Minerva Med; 1957 May; 48(37 Suppl):1659-82. PubMed ID: 13451348 [No Abstract] [Full Text] [Related]
36. [Comparative research on the clinical effectiveness of chemically-similar pyrazole derivatives]. GOBEL P Arzneimittelforschung; 1958 Nov; 8(11):700-6. PubMed ID: 13607306 [No Abstract] [Full Text] [Related]
37. [Association of 1-oxy-3-hydroxy-isoindoline and phenylbutazone in the treatment of some types of rheumatism]. CASADEMONT M; ALEGRE-MARCET C Rev Esp Reum Enferm Osteoartic; 1961 Jul; 9():146-51. PubMed ID: 13877031 [No Abstract] [Full Text] [Related]
38. The status of G-27202 (metabolite 1 of phenylbutazone) in the treatment of rheumatic disorders. GRAHAM W Can Med Assoc J; 1960 May; 82(20):1005-8. PubMed ID: 13828827 [No Abstract] [Full Text] [Related]
39. [Treatment of rheumatism in childhood with irgapyrin]. REY SUMAY RS; FRASCHINA HL Dia Med; 1957 Apr; 29(24):678-80. PubMed ID: 13447671 [No Abstract] [Full Text] [Related]
40. Phenylbutazone as a therapeutic agent in rheumatic diseases: its present status. STEINBROCKER O; ARGYROS TG Arthritis Rheum; 1960 Aug; 3():368-75. PubMed ID: 13834181 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]